Magazine Article | March 1, 2021

Enanta Pharmaceuticals: From Failure To Formidable

Source: Life Science Leader

By Rob Wright, Chief Editor, Life Science Leader
Follow Me On Twitter @RfwrightLSL

IMAGINE YOU WERE APPROACHED BY A RECRUITER WITH THE FOLLOWING PITCH:

CEO wanted for life sciences company that recently experienced significant failure. Provisos? Company currently has no investable assets. You won’t be able to raise any additional money, as the investors on the board want to avoid dilution. Chances of going public reside somewhere between slim and none.

And oh, by the way, your first order of business will be to lay off two-thirds of the company.

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: